4//SEC Filing
Schmid Kevin 4
Accession 0001013762-23-001575
CIK 0001074871other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:05 PM ET
Size
8.7 KB
Accession
0001013762-23-001575
Insider Transaction Report
Form 4
Schmid Kevin
Chief Operating Officer
Transactions
- Award
Option to purchase common stock
2023-10-02$1.11/sh+18,769$20,834→ 18,769 totalExercise: $1.11Exp: 2033-10-02→ Common Stock (18,769 underlying) - Award
Option to purchase common stock
2023-10-02$1.11/sh+37,538$41,667→ 37,538 totalExercise: $1.11Exp: 2033-10-02→ Common Stock (37,538 underlying)
Footnotes (3)
- [F1]This option shall vest as to all of the shares subject to the option if (i) all verification and validation testing for the Registrant's initial pump product is completed by December 31, 2023 and (ii) the 510(K) premarket submission to the U.S. Food and Drug Administration ("FDA") for the Registrant's initial pump product is completed by January 31, 2024. If criteria (i) and (ii) are not both achieved, the option will not vest as to any of the shares and will terminate on February 1, 2024.
- [F2]In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."
- [F3]This option shall vest as to all of the shares subject to the option if the Registrant receives notification of FDA clearance of the 510(K) premarket submission on or before August 1, 2024. If notification is not received on or before that date, the option will not vest as to any of the shares and will terminate on August 2, 2024.
Documents
Issuer
Modular Medical, Inc.
CIK 0001074871
Entity typeother
Related Parties
1- filerCIK 0001395775
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:05 PM ET
- Size
- 8.7 KB